A One Stop Shop for Everything Futures Trading

From RJO Futures | Ad

Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!

Download your FREE Technical Analysis Trading Guide Today.

CLDX Insider Trading (Celldex Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,463,359.00

Celldex Therapeutics Insider Trading History Chart

Celldex Therapeutics Share Price & Price History

^$37.33

▲ +2.8 (8.11%)

As of 08/12/2022 01:00 AM ET

Days: 30 | 90 | 365

Tailor an Options Trading Strategy to Fit Your Needs

From RJO Futures | Ad

This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.

Download your FREE Options Strategy Guide Today.

Celldex Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/23/2021	Samuel Bates Martin	CFO	Sell	9,500	$42.00	$399,000.00
12/8/2021	Elizabeth Crowley	VP	Sell	4,000	$40.00	$160,000.00
12/8/2021	Sarah B. Cavanaugh	SVP	Sell	7,323	$40.00	$292,920.00
11/15/2021	Samuel Bates Martin	CFO	Sell	9,500	$43.57	$413,915.00
11/12/2021	Diane C. Young	SVP	Sell	4,600	$42.94	$197,524.00
8/11/2021	Freddy A. Jimenez	SVP	Buy	430	$46.28	$19,900.40	430
8/10/2021	Samuel Bates Martin	CFO	Sell	2,738	$45.25	$123,894.50
12/14/2020	Richard M. Wright	VP	Sell	20,832	$18.61	$387,683.52
6/11/2020	Diane C. Young	SVP	Buy	2,115	$4.73	$10,003.95	2,115
6/9/2020	Anthony S. Marucci	CEO	Buy	15,000	$2.99	$44,850.00
6/9/2020	James J Marino	Director	Buy	8,305	$2.99	$24,831.95	12,704
6/9/2020	Margo Heath-Chiozzi	SVP	Buy	1,000	$2.99	$2,990.00	1,000
6/9/2020	Samuel Bates Martin	CFO	Buy	9,750	$2.99	$29,152.50
6/9/2020	Tibor Keler	VP	Buy	5,000	$2.99	$14,950.00	7,357

A One Stop Shop for Everything Futures Trading

From RJO Futures | Ad

Download your FREE Technical Analysis Trading Guide Today.

SEC Filings (Institutional Ownership Changes) for Celldex Therapeutics (NASDAQ:CLDX)

98.61% of Celldex Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Celldex Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/13/2022	Zurcher Kantonalbank Zurich Cantonalbank	3,783	$0.10M	0.0%	-32.6%	0.008%
8/13/2022	American International Group Inc.	21,449	$0.58M	0.0%	-6.1%	0.046%
8/12/2022	Northern Trust Corp	423,667	$11.42M	0.0%	-3.6%	0.906%
8/12/2022	Virtus ETF Advisers LLC	4,816	$0.13M	0.0%	+16.6%	0.010%
8/12/2022	Credit Suisse AG	29,907	$0.81M	0.0%	+3.4%	0.064%
8/12/2022	Rafferty Asset Management LLC	123,806	$3.34M	0.0%	-20.8%	0.265%
8/12/2022	FMR LLC	7,013,144	$189.07M	0.0%	+0.0%	14.995%
8/12/2022	BNP Paribas Arbitrage SA	9,906	$0.27M	0.0%	+162.0%	0.021%
8/12/2022	Rhumbline Advisers	64,958	$1.75M	0.0%	+24.4%	0.139%
8/11/2022	Deutsche Bank AG	170,214	$4.59M	0.0%	+127.4%	0.364%
8/11/2022	Alps Advisors Inc.	27,740	$0.75M	0.0%	N/A	0.059%
8/11/2022	JPMorgan Chase & Co.	42,346	$1.14M	0.0%	+21.4%	0.091%
8/10/2022	Principal Financial Group Inc.	8,638	$0.23M	0.0%	-79.7%	0.018%
8/10/2022	WINTON GROUP Ltd	8,322	$0.22M	0.0%	N/A	0.018%
8/5/2022	Mirador Capital Partners LP	106,368	$2.87M	0.7%	+18.1%	0.228%
8/4/2022	TD Asset Management Inc.	36,661	$0.99M	0.0%	-50.3%	0.078%
8/3/2022	Candriam S.C.A.	290,794	$7.84M	0.1%	+4.8%	0.622%
8/1/2022	Victory Capital Management Inc.	18,687	$0.50M	0.0%	+7.2%	0.040%
7/29/2022	SG Americas Securities LLC	55,755	$1.50M	0.0%	+299.4%	0.119%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	13,749	$0.37M	0.0%	N/A	0.029%
7/25/2022	Allspring Global Investments Holdings LLC	2,403	$64K	0.0%	-89.8%	0.005%
7/21/2022	TSP Capital Management Group LLC	266,545	$7.19M	2.8%	-0.9%	0.570%
6/30/2022	Amalgamated Bank	7,080	$0.24M	0.0%	-7.3%	0.015%
6/7/2022	Teachers Retirement System of The State of Kentucky	32,242	$1.10M	0.0%	+44.1%	0.069%
6/7/2022	Bank of America Corp DE	180,894	$6.16M	0.0%	+91.5%	0.387%
6/2/2022	Verition Fund Management LLC	87,230	$2.97M	0.0%	+62.0%	0.187%
5/27/2022	Walleye Capital LLC	37,381	$1.27M	0.0%	+162.7%	0.080%
5/20/2022	The Manufacturers Life Insurance Company	63,511	$2.19M	0.0%	+172.7%	0.136%
5/18/2022	BNP Paribas Arbitrage SA	3,781	$0.13M	0.0%	-74.1%	0.008%
5/17/2022	Walleye Capital LLC	37,381	$1.27M	0.0%	+162.7%	0.080%
5/17/2022	Kiwi Wealth Investments Limited Partnership	27,477	$0.94M	0.1%	-47.1%	0.059%
5/17/2022	Point72 Hong Kong Ltd	1,394	$47K	0.0%	+57.9%	0.003%
5/17/2022	Polar Asset Management Partners Inc.	69,200	$2.36M	0.0%	N/A	0.148%
5/17/2022	Polar Capital Holdings Plc	1,250,000	$42.58M	0.2%	+25.0%	2.674%
5/17/2022	RA Capital Management L.P.	2,075,000	$70.68M	1.5%	+15.0%	4.439%
5/17/2022	Royal Bank of Canada	2,829	$96K	0.0%	-70.4%	0.006%
5/17/2022	RTW Investments LP	3,084,215	$105.05M	2.2%	-21.4%	6.597%
5/17/2022	Rock Springs Capital Management LP	97,317	$3.32M	0.1%	N/A	0.208%
5/17/2022	Sessa Capital IM L.P.	212,000	$7.22M	0.3%	N/A	0.453%
5/17/2022	Eventide Asset Management LLC	1,445,700	$49.24M	0.8%	+16.7%	3.092%
5/16/2022	California State Teachers Retirement System	51,457	$1.75M	0.0%	-8.9%	0.110%
5/16/2022	Goldman Sachs Group Inc.	303,419	$10.34M	0.0%	+19.4%	0.649%
5/16/2022	Viking Global Investors LP	1,846,647	$62.90M	0.3%	+143.7%	3.950%
5/16/2022	Woodline Partners LP	579,192	$19.73M	0.3%	+122.9%	1.239%
5/16/2022	Wellington Management Group LLP	3,529,840	$120.23M	0.0%	+61.5%	7.550%
5/16/2022	State Street Corp	2,682,728	$91.37M	0.0%	+13.3%	5.738%
5/16/2022	Eversept Partners LP	636,453	$21.68M	1.8%	+7.4%	1.361%
5/16/2022	Engineers Gate Manager LP	7,086	$0.24M	0.0%	N/A	0.015%
5/16/2022	Ghost Tree Capital LLC	300,000	$10.22M	2.2%	-14.3%	0.642%
5/16/2022	Invesco Ltd.	18,123	$0.62M	0.0%	-91.3%	0.039%
5/16/2022	UBS Group AG	160,779	$5.48M	0.0%	+23.1%	0.344%
5/13/2022	Silverarc Capital Management LLC	45,538	$0.26M	0.1%	+0.9%	0.097%
5/13/2022	Northern Trust Corp	439,534	$14.97M	0.0%	-5.3%	0.940%
5/13/2022	Verition Fund Management LLC	87,230	$2.97M	0.0%	+62.0%	0.187%
5/13/2022	Charles Schwab Investment Management Inc.	336,808	$11.47M	0.0%	+2.7%	0.720%
5/13/2022	Affinity Asset Advisors LLC	125,000	$4.26M	0.7%	+25.0%	0.267%
5/13/2022	First Trust Advisors LP	52,773	$1.80M	0.0%	-48.2%	0.113%
5/13/2022	American International Group Inc.	22,831	$0.78M	0.0%	-6.6%	0.049%
5/13/2022	Ergoteles LLC	11,702	$0.40M	0.0%	-27.6%	0.025%
5/13/2022	DLD Asset Management LP	7,700	$0.26M	0.0%	N/A	0.016%
5/13/2022	Candriam Luxembourg S.C.A.	277,481	$9.45M	0.1%	-28.3%	0.594%
5/13/2022	Vanguard Group Inc.	2,433,595	$82.89M	0.0%	+0.9%	5.206%
5/13/2022	Kynam Capital Management LP	753,034	$25.65M	8.3%	+232.1%	1.611%
5/13/2022	Dimensional Fund Advisors LP	592,358	$20.18M	0.0%	+31.8%	1.267%
5/12/2022	TSP Capital Management Group LLC	269,045	$9.16M	3.1%	+6.1%	0.575%
5/12/2022	Gyon Technologies Capital Management LP	10,552	$0.36M	0.3%	-42.6%	0.023%
5/12/2022	BlackRock Inc.	3,046,822	$103.77M	0.0%	-1.7%	6.517%
5/12/2022	Rhumbline Advisers	52,219	$1.78M	0.0%	+4.8%	0.112%
5/12/2022	Metropolitan Life Insurance Co NY	2,996	$0.10M	0.0%	-75.3%	0.006%
5/12/2022	MetLife Investment Management LLC	25,208	$0.86M	0.0%	+57.0%	0.054%
5/12/2022	E Fund Management Co. Ltd.	7,838	$0.27M	0.0%	N/A	0.017%
5/12/2022	HighTower Advisors LLC	10,218	$0.35M	0.0%	N/A	0.022%
5/11/2022	American Century Companies Inc.	183,017	$6.23M	0.0%	-0.8%	0.391%
5/11/2022	JPMorgan Chase & Co.	34,888	$1.19M	0.0%	-365.0%	0.075%
5/11/2022	GMT Capital Corp	204,535	$6.97M	0.4%	N/A	0.437%
5/10/2022	ProShare Advisors LLC	8,628	$0.29M	0.0%	-14.1%	0.018%
5/10/2022	TD Asset Management Inc.	73,829	$2.52M	0.0%	+18.5%	0.158%
5/9/2022	Campbell & CO Investment Adviser LLC	8,692	$0.30M	0.1%	+14.4%	0.019%
5/9/2022	Principal Financial Group Inc.	42,489	$1.45M	0.0%	-26.2%	0.091%
5/9/2022	Swiss National Bank	88,200	$3M	0.0%	+7.7%	0.189%
5/9/2022	Teacher Retirement System of Texas	7,745	$0.26M	0.0%	+8.3%	0.017%
5/6/2022	HC Advisors LLC	7,675	$0.26M	0.2%	-6.2%	0.016%
5/6/2022	Mirador Capital Partners LP	90,048	$3.07M	0.6%	+4.6%	0.193%
5/4/2022	ClariVest Asset Management LLC	16,400	$0.56M	0.0%	-12.3%	0.035%
5/4/2022	Prospera Financial Services Inc	2,622	$89K	0.0%	N/A	0.006%
5/4/2022	Victory Capital Management Inc.	17,424	$0.53M	0.0%	+12.5%	0.037%
4/29/2022	SG Americas Securities LLC	13,960	$0.48M	0.0%	+38.4%	0.030%
4/29/2022	Nisa Investment Advisors LLC	1,390	$47K	0.0%	-37.2%	0.003%
4/21/2022	Zurcher Kantonalbank Zurich Cantonalbank	5,610	$0.19M	0.0%	+35.1%	0.012%
3/3/2022	Walleye Capital LLC	14,227	$0.55M	0.0%	N/A	0.030%
2/25/2022	AlphaCentric Advisors LLC	17,000	$0.66M	0.2%	N/A	0.036%
2/23/2022	Barclays PLC	139,952	$5.41M	0.0%	+251.9%	0.300%
2/19/2022	Woodline Partners LP	259,895	$10.04M	0.1%	N/A	0.557%
2/16/2022	Ghost Tree Capital LLC	350,000	$13.52M	4.8%	+37.3%	0.750%
2/16/2022	SG3 Management LLC	17,500	$0.68M	0.0%	-67.9%	0.038%
2/15/2022	Sofinnova Investments Inc.	271,533	$10.49M	0.6%	+98.2%	0.582%
2/15/2022	Kennedy Capital Management Inc.	28,158	$1.09M	0.0%	N/A	0.060%
2/15/2022	Adage Capital Partners GP L.L.C.	650,000	$25.12M	0.0%	-31.6%	1.393%
2/14/2022	Canada Pension Plan Investment Board	23,600	$0.91M	0.0%	+114.5%	0.051%
2/14/2022	PDT Partners LLC	16,327	$0.63M	0.0%	N/A	0.035%

Data available starting January 2016

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity; CDX-1140, a human agonist monoclonal antibody targeted to CD40, a key activator of immune response, which is found on dendritic cells, macrophages, and B cells, as well as is expressed on various cancer cells; and CDX-527, a bispecific antibody, which uses the company's proprietary active anti-PD-L1 and CD27 human antibodies to couple CD27 costimulation with blockade of the PD-L1/PD-1 pathway to help prime and activate anti-tumor T cell responses through CD27 costimulation. The company has research collaboration and license agreements with University of Southampton to develop human antibodies towards CD27; Amgen Inc. with exclusive rights to CDX-301 and CD40 ligand; and Yale University. Celldex Therapeutics, Inc. was incorporated in 1983 and is headquartered in Hampton, New Jersey.

Today's Range

Now: $37.33

$34.31

$37.98

50 Day Range

MA: $27.91

$20.50

$37.47

52 Week Range

Now: $37.33

$19.85

$57.20

Volume

582,593 shs

Average Volume

563,335 shs

Market Capitalization

$1.75 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.43

Who are the company insiders with the largest holdings of Celldex Therapeutics?: Celldex Therapeutics' top insider investors include:
Freddy A Jimenez (SVP)
Diane C Young (SVP)
Elizabeth Crowley (VP)
Richard M Wright (VP)
Samuel Bates Martin (CFO)
Sarah Cavanaugh (SVP)
Learn More about top insider investors at Celldex Therapeutics.
Who are the major institutional investors of Celldex Therapeutics?: Celldex Therapeutics' top institutional investors include:
FMR LLC — 14.99%
Ikarian Capital LLC — 0.00%
Northern Trust Corp — 0.91%
Candriam S.C.A. — 0.62%
TSP Capital Management Group LLC — 0.57%
Deutsche Bank AG — 0.36%
Learn More about top institutional investors of Celldex Therapeutics stock.
Which institutional investors are selling Celldex Therapeutics stock?: During the previous quarter, CLDX stock was sold by these institutional investors:
TD Asset Management Inc.
Principal Financial Group Inc.
Rafferty Asset Management LLC
Allspring Global Investments Holdings LLC
Walleye Trading LLC
Northern Trust Corp
TSP Capital Management Group LLC
Zurcher Kantonalbank Zurich Cantonalbank
During the previous year, company insiders that have sold Celldex Therapeutics company stock include:
Freddy A Jimenez (SVP)
Diane C Young (SVP)
Elizabeth Crowley (VP)
Richard M Wright (VP)
Learn More investors selling Celldex Therapeutics stock.
Which institutional investors are buying Celldex Therapeutics stock?: During the previous quarter, CLDX stock was purchased by institutional investors including:
Deutsche Bank AG
SG Americas Securities LLC
DLD Asset Management LP
Silverarc Capital Management LLC
Alps Advisors Inc.
Simplex Trading LLC
Group One Trading L.P.
Ikarian Capital LLC

Tailor an Options Trading Strategy to Fit Your Needs

From RJO Futures | Ad

This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.

Download your FREE Options Strategy Guide Today.

CLDX Insider Trading (Celldex Therapeutics)

Celldex Therapeutics Insider Trading History Chart

Celldex Therapeutics Share Price & Price History

Celldex Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Celldex Therapeutics (NASDAQ:CLDX)

Institutional Buying and Selling by Quarter

Celldex Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Celldex Therapeutics?

Who are the major institutional investors of Celldex Therapeutics?

Which institutional investors are selling Celldex Therapeutics stock?

Which institutional investors are buying Celldex Therapeutics stock?